Drugmakers Throw Purdue Under Bus In Opioid Trial Gamble
Law360 (May 21, 2021, 9:35 PM EDT) -- Major pharmaceutical companies embroiled in a multibillion-dollar opioid trial are pinning blame for rampant abuse of prescription narcotics on fellow drugmaker Purdue Pharma, gambling that they can impugn Purdue's marketing of OxyContin without incriminating their own promotion of painkillers.
Big Pharma's finger-pointing has played out during a momentous trial pitting California municipalities against drugmakers accused of deceiving doctors about addiction risks in much the same way as Purdue, which avoided the trial because of its bankruptcy.
"Let's talk about who Endo is not. Endo was no Purdue — not even close," Hueston Hennigan LLP partner John C. Hueston said in defense...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!